Brief: Brain+: Rox Health Approves German Version Of Brain+'s First Digital Dementia Product

Brain+ A/S

12/10/2022 07:04

Oct 12 (Reuters) - Brain+ A/S  BRAINP.CO :
    * BRAIN+ MEETS THE FIRST MILESTONE IN ITS PHARMA PARTNERSHIP
WITH
ROX HEALTH (ROCHE GERMANY) ON ITS DIGITAL COGNITIVE STIMULATION
THERAPY PRODUCTS
    * ROX HEALTH HAS APPROVED GERMAN VERSION OF BRAIN+'S FIRST
DIGITAL
DEMENTIA PRODUCT, CST-THERAPIST COMPANION, FOR COMMERCIAL LAUNCH
    * MEETING THIS MILESTONE UNLOCKS ACCESS FOR BRAIN+ TO
ADDITIONAL
EXPERT RESOURCES IN ROX HEALTH/ROCHE ORGANIZATION AND TRIGGERS A
MINOR MILESTONE PAYMENT
    * NEXT MILESTONES WILL BE PRODUCT LAUNCH IN GERMANY,
TARGETED FOR
Q2 2023, AND GETTING FIRST GERMAN CUSTOMERS

Source text for Eikon:  ID:nWkr3YVchX 
Further company coverage:  BRAINP.CO 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))